Peptides were synthesized based on the amino acid sequences of the epitopes predicted to bind to various DRB1 alleles, and IFN-γ ELISPOT was conducted using PBMCs obtained from the HCC patients. This evidence concerns the gene HLA-DRB1 and hepatocellular carcinoma.